Paola Santoro

Paola Santoro is a Clinical Trial Director at Ariceum Therapeutics, overseeing phase I and II trials in small cell lung cancer (SCLC) and Merkel cell carcinoma (MCC), and leading the development of global trial protocols. Previously, Paola held the position of Global Trial Director at Novartis, where contributions included leading pivotal trials for the marketing authorization of Lutathera. Earlier experience includes serving as Associate Director of Clinical Development Operations at Advanced Accelerator Applications and Senior International Project Manager at Phidea Marvin, coordinating international clinical trials across various therapeutic areas. Paola's career began at OPIS s.r.l., rising through roles from Clinical Project Manager to Clinical Data Manager. Paola holds a Master of Science in Biology from Università degli Studi di Milano and has completed a Project Management course at SDA Bocconi.